Unknown

Dataset Information

Impella use in real-world cardiogenic shock patients: Sobering outcomes.


ABSTRACT:

Background

Critically ill patients with cardiogenic shock could benefit from ventricular assist device support using the Impella microaxial blood pump. However, recent studies suggested Impella not to improve outcomes. We, therefore, evaluated outcomes and predictors in a real-world scenario.

Methods

In this retrospective single-center trial, 125 patients suffering from cardiac arrest/cardiogenic shock between 2008 and 2018 were analyzed. 93 Patients had a prior successful cardiopulmonary resuscitation. The primary endpoint was hospital mortality. Associations of covariates with the primary endpoint were assessed by univariable and multivariable logistic regression. Adjusted odds ratios (aOR) and optimal cut-offs (using Youden index) were obtained.

Results

Hospital mo

SUBMITTER: Abdullah KQA 

PROVIDER: S-EPMC7909706 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature